Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $3.05 Million - $3.99 Million
35,000 Added 87.5%
75,000 $8.05 Million
Q2 2021

Aug 13, 2021

BUY
$100.34 - $115.69 $4.01 Million - $4.63 Million
40,000 New
40,000 $4.33 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Avalon Global Asset Management LLC Portfolio

Follow Avalon Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Global Asset Management LLC with notifications on news.